164 related articles for article (PubMed ID: 27986596)
1. Effects of the synthetic neurosteroid ganaxolone on seizure activity and behavioral deficits in an Angelman syndrome mouse model.
Ciarlone SL; Wang X; Rogawski MA; Weeber EJ
Neuropharmacology; 2017 Apr; 116():142-150. PubMed ID: 27986596
[TBL] [Abstract][Full Text] [Related]
2. Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy.
Reddy DS; Rogawski MA
J Pharmacol Exp Ther; 2000 Sep; 294(3):909-15. PubMed ID: 10945840
[TBL] [Abstract][Full Text] [Related]
3. Reelin supplementation recovers synaptic plasticity and cognitive deficits in a mouse model for Angelman syndrome.
Hethorn WR; Ciarlone SL; Filonova I; Rogers JT; Aguirre D; Ramirez RA; Grieco JC; Peters MM; Gulick D; Anderson AE; L Banko J; Lussier AL; Weeber EJ
Eur J Neurosci; 2015 May; 41(10):1372-80. PubMed ID: 25864922
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism.
Kazdoba TM; Hagerman RJ; Zolkowska D; Rogawski MA; Crawley JN
Psychopharmacology (Berl); 2016 Jan; 233(2):309-23. PubMed ID: 26525567
[TBL] [Abstract][Full Text] [Related]
5. Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone.
Beekman M; Ungard JT; Gasior M; Carter RB; Dijkstra D; Goldberg SR; Witkin JM
J Pharmacol Exp Ther; 1998 Mar; 284(3):868-77. PubMed ID: 9495844
[TBL] [Abstract][Full Text] [Related]
6. Isobolographic Analysis of Antiseizure Activity of the GABA Type A Receptor-Modulating Synthetic Neurosteroids Brexanolone and Ganaxolone with Tiagabine and Midazolam.
Chuang SH; Reddy DS
J Pharmacol Exp Ther; 2020 Mar; 372(3):285-298. PubMed ID: 31843812
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome model.
Chung L; Bey AL; Towers AJ; Cao X; Kim IH; Jiang YH
Neurobiol Dis; 2018 Feb; 110():12-19. PubMed ID: 29097328
[TBL] [Abstract][Full Text] [Related]
8. Ketone ester supplementation attenuates seizure activity, and improves behavior and hippocampal synaptic plasticity in an Angelman syndrome mouse model.
Ciarlone SL; Grieco JC; D'Agostino DP; Weeber EJ
Neurobiol Dis; 2016 Dec; 96():38-46. PubMed ID: 27546058
[TBL] [Abstract][Full Text] [Related]
9. Ganaxolone, a selective, high-affinity steroid modulator of the gamma-aminobutyric acid-A receptor, exacerbates seizures in animal models of absence.
Snead OC
Ann Neurol; 1998 Oct; 44(4):688-91. PubMed ID: 9778270
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant doses of ganaxolone do not compromise motor performance in immature rats.
Mares P; Stehlíková M
Neurosci Lett; 2010 Jan; 469(3):396-9. PubMed ID: 20026384
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of synaptic plasticity and reversal of impairments in motor and cognitive functions in a mouse model of Angelman Syndrome by a small neurogenic molecule, NSI-189.
Liu Y; Johe K; Sun J; Hao X; Wang Y; Bi X; Baudry M
Neuropharmacology; 2019 Jan; 144():337-344. PubMed ID: 30408487
[TBL] [Abstract][Full Text] [Related]
12. Ampakines promote spine actin polymerization, long-term potentiation, and learning in a mouse model of Angelman syndrome.
Baudry M; Kramar E; Xu X; Zadran H; Moreno S; Lynch G; Gall C; Bi X
Neurobiol Dis; 2012 Aug; 47(2):210-5. PubMed ID: 22525571
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.
Carter RB; Wood PL; Wieland S; Hawkinson JE; Belelli D; Lambert JJ; White HS; Wolf HH; Mirsadeghi S; Tahir SH; Bolger MB; Lan NC; Gee KW
J Pharmacol Exp Ther; 1997 Mar; 280(3):1284-95. PubMed ID: 9067315
[TBL] [Abstract][Full Text] [Related]
14. Modification of behavioral effects of drugs in mice by neuroactive steroids.
Ungard JT; Beekman M; Gasior M; Carter RB; Dijkstra D; Witkin JM
Psychopharmacology (Berl); 2000 Mar; 148(4):336-43. PubMed ID: 10928304
[TBL] [Abstract][Full Text] [Related]
15. Strain-dependence of the Angelman Syndrome phenotypes in Ube3a maternal deficiency mice.
Born HA; Dao AT; Levine AT; Lee WL; Mehta NM; Mehra S; Weeber EJ; Anderson AE
Sci Rep; 2017 Aug; 7(1):8451. PubMed ID: 28814801
[TBL] [Abstract][Full Text] [Related]
16. Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model.
Reddy DS; Rogawski MA
Epilepsy Res; 2010 May; 89(2-3):254-60. PubMed ID: 20172694
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a TrkB agonist on spatial and motor learning in the
Schultz MN; Crawley JN
Learn Mem; 2020 Sep; 27(9):346-354. PubMed ID: 32817301
[TBL] [Abstract][Full Text] [Related]
18. Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself.
Reddy DS; Rogawski MA
J Pharmacol Exp Ther; 2000 Dec; 295(3):1241-8. PubMed ID: 11082461
[TBL] [Abstract][Full Text] [Related]
19. Zinc reduces antiseizure activity of neurosteroids by selective blockade of extrasynaptic GABA-A receptor-mediated tonic inhibition in the hippocampus.
Chuang SH; Reddy DS
Neuropharmacology; 2019 Apr; 148():244-256. PubMed ID: 30471294
[TBL] [Abstract][Full Text] [Related]
20. Lack of UBE3A-Mediated Regulation of Synaptic SK2 Channels Contributes to Learning and Memory Impairment in the Female Mouse Model of Angelman Syndrome.
Sun J; Liu Y; Hao X; Baudry M; Bi X
Neural Plast; 2022; 2022():3923384. PubMed ID: 36237484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
